Central nervous system (CNS) toxicity accounts for 25% of safety failures across drug discovery and development, yet it is rarely detected during standard GLP toxicology studies 1. Seizure risk ...
The blood-brain barrier functions as a tightly regulated biological filter, shielding brain tissue from harmful substances traveling through the bloodstream. While this defense mechanism is vital for ...
A new report published by the Tufts Center for the Study of Drug Development (CSDD) validates longstanding data indicating that drugs intended to treat disorders of Central Nervous System (CNS) take ...
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this ...
Inflammatory pathways involving microglia, astrocytes, and cytokine signaling are widely implicated in disorders including Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, and ...
Praxis Precision Medicines, Inc. (PRAX) stock is soaring in trading today, up 35% at time of writing, with shares reaching a value of $260, their highest value since the beginning of 2022. Current ...
Xywav (calcium, magnesium, potassium, and sodium oxybates) is a prescription drug that works to treat certain sleep disorders by slowing central nervous system activity. Your response to this drug may ...
Despite years of guidelines cautioning against their use, potentially inappropriate central nervous system (CNS)-active medications are commonly prescribed to older adults —particularly those with ...
In this open-label Phase 1b study (NCT06395285), six adult patients with genetically confirmed ROSAH syndrome completed 28 days of once-daily oral DF-003 treatment followed by post-treatment ...
Adjunct Associate Professor, Albany College of Pharmacy/Union University, Albany, New York; Clinical Pharmacy Specialist, Stratten VA Medical Center, Albany, New York Morphine preserved with phenol ...
The CNS field has been waiting far too long for a true breakthrough in brain-targeted drug delivery. Despite decades of R&D and countless promising candidates, the blood-brain barrier remains the ...